Smarttouch catheter was in close proximity to another catheter during cti ablation, but not post-cti ablation, when the tamponade was discovered.Smarttouch catheter was zeroed after the initial warm-up phase post catheter connection to the carto 3 patient interface unit.There is no information regarding the carto 3 system indicating to re-zero the catheter.There were no errors reported on any bwi equipment during the procedure.Since two ablation catheters were used prior to the adverse event, this event is being reported under both catheters.This complaint is for the first catheter used with the temperature issue.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.As such, the investigation will be closed.If the complaint device is received in the future we will reopen the complaint and perform the investigation as appropriate.Since no lot number was provided, no device history record (dhr) review could be performed.Concomitant: st.Jude medical transseptal needle.St.Jude medical agilis long curve sheath.Smartablate generator.Full udi # information unavailable since the lot number is unknown.(b)(4) are related to the same incident.
|
It was reported that a male patient underwent a cavotricuspid isthmus (cti) ablation procedure for atrial flutter with two thermocool® smarttouch® bi-directional navigation catheters and suffered a cardiac tamponade requiring pericardiocentesis.Prior to the adverse event, there was no temperature displayed on the smartablate generator.The smarttouch catheter was replaced and the issue resolved.This event is not mdr reportable because the potential that it could cause or contribute to a death or serious injury, or other significant adverse event, is remote.During the procedure, while using smarttouch catheter #2, the patient became hypotensive and a tamponade was confirmed via ultrasound while screening the right atrium, right ventricle, and left ventricle.A pericardiocentesis was performed and yielded approximately 2000 ml of fluid.Patient was reported to be in stable condition.Patient required an overnight stay in the hospital for monitoring.Patient has fully recovered.It was noted that there was no baseline effusion and that the injury occurred post-cti ablation, while returning to the left atrium.There were no factors cited that may have contributed to the adverse event.Physician¿s opinion regarding the cause of the adverse event is that it was a result of a mechanical tear or product handling.Transseptal puncture was performed with a st.Jude medical transseptal needle.Sheath used was a st.Jude medical agilis long curve.Generator was set on power control mode at 25-30 watts with contact force ranging from 10-20 grams.There is no information regarding generator settings at the time of injury, power titration, overall ablation time at the site of injury, last ablation cycle time at the site of injury, or irrigated catheter flow setting.Patient received anticoagulant during the procedure with an activated clotting time that decreased and was eventually raised to the 100s (seconds).
|